Kyra

ANDA 202318, held by Sun Pharm. Drospirenone; Ethinyl Estradiol.

As of Nov 15, 2026, ANDA 202318 (Kyra), held by Sun Pharm, was first approved by FDA on Jul 23, 2019, with 0 approved supplements and 0 published complete response letters.

• First approved: Jul 23, 2019
• Supplements approved: 0
• Complete response letters: 0

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters